Part Two: Rotavirus Got Cancelled, and Honestly It Had It Coming
Welcome to “Remember When Kids Just Died?” A daily two-part tour through every vaccine-preventable disease, starting with polio on September 1, 2026 and ending with Tetanus on September 15, 2026. Each disease gets two posts: the pre-vaccine era, when parents enjoyed the character-building experience of burying their children, and the post-vaccine era, when we ruined everything by making childhood survivable. Cramming both into one post felt disrespectful, to the corpses and the Nobel Prizes.
In the last installment, we established that rotavirus was running the most successful hostile takeover in pediatric history: 95% market share, a billion dollars a year, and an unbroken winter touring schedule. Then, in 2006, something extremely rude happened to it. Somebody invented a vaccine.
The part where the graph falls off a cliff
Look, I have looked at a lot of public health data. Most of it is subtle. You squint, you adjust for confounders, you write “a modest but statistically significant trend” and hope nobody asks follow-up questions.
Rotavirus is not that. Rotavirus data post vaccine looks like someone unplugged something. Median declines of 80% in rotavirus-associated hospitalizations and 57% in emergency department visits, with pooled vaccine effectiveness of 84% for RotaTeq and 83% for Rotarix against hospitalization and ED visits. In commercially insured children from 2007–2011, routine vaccination averted an estimated annual average of 280,000 clinic visits, 62,000 ED visits, and 45,000 hospitalizations among kids under 5.
Forty-five thousand hospitalizations a year. Gone. Just, not happening anymore. Somewhere out there are 45,000 annual parents who never had to spend a February night watching a monitor, and every single one of them has no idea. You cannot feel a hospitalization you didn’t have. It’s the worst marketing problem in medicine.
The freeloaders
Here’s my favorite part, and it is genuinely funny. The vaccine goes into babies. It protects babies. Fine, expected, that’s the label.
But rotavirus hospitalizations also dropped in 5–19 year olds, in 20–59 year olds, and even in people 60 and older, who were never within a hundred miles of an oral infant vaccine. Turns out babies were the distribution network. Shut down the babies, shut down the whole operation. Grandpa got protected from rotavirus by a two month old, which is the closest thing epidemiology has to a heist movie.
There’s even a weird side effect of partial coverage: with vaccination rates in the 59%–73% range for years, susceptible kids accumulated across two birth cohorts and rotavirus started showing up in a biennial every other year pattern instead of annually. The virus went from an annual subscription to a bad reunion tour, and the pattern has been fading as coverage climbed.
How anybody knows it’s safe (the boring part that is actually the point)
Here’s the thing worth taking seriously, and it’s the reason I trust this vaccine rather than just liking the numbers. The United States has already pulled a rotavirus vaccine off the market. In 1999, an earlier product was withdrawn after surveillance picked up intussusception, a bowel telescoping problem, and the detection story is remarkable: retrospective data mining of the passive reporting system flagged the rotavirus intussusception signal as early as February 1999, when only four cases had been reported, well before the eventual 112 documented cases accumulated.
Four cases. Nationwide. That’s the sensitivity we’re talking about. Two systems do the heavy lifting. VAERS, co-managed by CDC and FDA since 1990 under the National Childhood Vaccine Injury Act, is the passive front line, anyone can file a report: doctors, manufacturers, parents, anyone, with no time limit on submission. It’s deliberately noisy. A VAERS report proves nothing on its own, which is precisely why people misquote it in bad faith. Its job is not to establish causation; its job is to be the smoke detector. Then the Vaccine Safety Datalink, CDC linked to large healthcare systems, does active surveillance with real denominators and real comparison groups to find out whether the smoke is a fire.
So when a parent asks me whether anyone is actually watching, the honest answer is: yes, and we have the receipts, because the system already caught a problem once and yanked the product. The current vaccines went out under that same surveillance and stayed. That’s not blind faith. That’s a track record of a system willing to fire its own product.
The unsatisfying ending
Rotavirus used to be weather. Now it’s trivia. And the reward for eliminating a disease that hospitalized 45,000 American children a year is that nobody remembers it existed, and some people now have the leisure time to argue on the internet about whether it was ever a big deal. It was.
I was there. Ask anyone who staffed a pediatric ED in February 2003.
Sources:
CDC, Epidemiology and Prevention of Vaccine-Preventable Diseases, Chapter 19: Rotavirus
CDC, A Decade of Experience with Rotavirus Vaccination in the United States: Vaccine Uptake, Effectiveness, and Impact
CDC, VPD Surveillance Manual, Chapter 21: Surveillance for Adverse Events Following Immunization (VAERS)